PCRX FY 2019 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$969M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$421M+24.8% YoY

Gross Profit

$314M74.7% margin

Operating Income

$10M2.5% margin

Net Income

-$11M-2.6% margin

EPS (Diluted)

$-0.27

Cash Flow

Operating Cash Flow

$71M

Free Cash Flow

$60M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$831M

Total Liabilities

$476M

Stockholders' Equity

$355M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$421M	$337M	+24.8%
Gross Profit	$314M	$250M	+25.5%
Operating Income	$10M	$16M	-34.2%
Net Income	-$11M	-$471,000	-2238.9%